| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 5.44M | - | - | |
| CEO | 1.80M | - | - | |
| Dir | 683.7K | - | - | |
| Dir | 333.5K | - | - | |
| Dir | 291.4K | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 26, 2025 | Mark L Pacala | Director | Buy | 90,562 | $1.04 | $94,338.44 | +67.4% | +94.2% | +156.2% | |
| Mar 26, 2025 | Karen Marie Johnson | Director | Buy | 36,224 | $1.04 | $37,734.54 | +21.7% | +94.2% | +156.2% | |
| Mar 26, 2025 | Brad Hively79 | Director | Buy | 9,056 | $1.04 | $9,433.64 | +1.4% | +94.2% | +156.2% | |
| Mar 26, 2025 | Jeremy Castle | Chief Operating Officer | Buy | 9,056 | $1.04 | $9,433.64 | +11.1% | +94.2% | +156.2% | |
| Mar 26, 2025 | Robert Ross Carter | Chief Financial Officer | Buy | 9,056 | $1.04 | $9,433.64 | +29.8% | +94.2% | +156.2% | |
| Mar 26, 2025 | Richard A Barasch56 | Director | Buy | 1,358,448 | $1.04 | $1,415,095.28 | +325.6% | +94.2% | +156.2% | |
| Dec 2, 2024 | Brad Hively79 | Director | Buy | 300,000 | $0.17 | $50,000.00 | +81.8% | +365.6% | +1803.5% | |
| Jan 29, 2024 | Havencrest Healthcare Partners, L.P.92 | 10% Owner | Sell | 8,637 | $2.12 | $18,310.44 | -100% | -49.8% | -63.6% | |
| Jan 26, 2024 | Havencrest Healthcare Partners, L.P.92 | 10% Owner | Sell | 43,776 | $2.21 | $96,835.30 | -83.5% | -44.6% | -64.3% | |
| Jan 23, 2024 | Havencrest Healthcare Partners, L.P.92 | 10% Owner | Sell | 27,587 | $2.12 | $58,550.92 | -34.5% | -46.4% | -66.6% |